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Drug addiction is a chronic disease characterized by recurring episodes of abstinence and
relapse. The precise mechanisms underlying this pattern are yet to be elucidated, but
stress is thought to be a major factor in relapse. Recently, we reported that rats under
withdrawal and exposed to a mild chronic stressor, prolonged food restriction, show
increased heroin seeking compared to sated controls. Previous studies demonstrated
a critical role for corticotropin-releasing factor (CRF) and corticosterone, hormones
involved in the stress response, in acute food deprivation-induced reinstatement of
extinguished drug seeking. However, the role of CRF and corticosterone in chronic
food restriction-induced augmentation of drug seeking remains unknown. Here, male
Long-Evans rats were trained to self-administer heroin for 10 days in operant conditioning
chambers. Rats were then removed from the training chambers, and subjected to 14
days of unrestricted (sated rats) or a mildly restricted (FDR rats) access to food, which
maintained their body weight (BW) at 90% of their baseline weight. On day 14, different
groups of rats were administered a selective CRF1 receptor antagonist (R121919; 0.0,
20.0mg/kg; s.c.), a non-selective CRF receptor antagonist (α-helical CRF; 0.0, 10.0,
25.0μg/rat; i.c.v.) or a glucocorticoid receptor antagonist (RU486; 0.0, 30.0mg/kg; i.p.),
and underwent a 1 h drug seeking test under extinction conditions. An additional group
of rats was tested following adrenalectomy. All FDR rats showed a statistically significant
increase in heroin seeking compared to the sated rats. No statistically significant effects
for treatment with α-helical CRF, R121919, RU486 or adrenalectomy were observed. These
findings suggest that stress may not be a critical factor in the augmentation of heroin
seeking in food-restricted rats.
Keywords: self-administration, chronic food restriction, corticotropin-releasing factor, corticosterone,
adrenalectomy, R121919, α-helical CRF, RU486
INTRODUCTION
Stress is consistently reported by drug users as a factor in subjec-
tive craving as well as in the initiation, maintenance, and relapse
of drug use (Brewer et al., 1998; Matheny andWeatherman, 1998;
Sinha and O’Malley, 1999; Sinha, 2001, 2008). A role for stress in
triggering relapse to drugs has also been identified in retrospec-
tive studies in which interviews and questionnaires were given
to addicts, as well as in controlled laboratory studies (Kosten
et al., 1983, 1986; Sinha et al., 2006). Of many potential stress-
ful life events, a particularly interesting one is exposure to caloric
restriction, which precipitates negative affective states, as well as
physiological changes including increases in circulating gluco-
corticoid levels (Dallman et al., 1999; Tomiyama et al., 2010).
Studies showing an increased risk for relapse among calorically
restricted abstinent smokers (Hall et al., 1992), and a positive
correlation between the severity of diet and the risk of drug
taking in young women (Krahn et al., 1992), suggest a strong
link between caloric restriction and drug intake. Moreover, in
humans, only prolonged food restriction, and not acute food
deprivation, is associated with increased drug taking (Zacny and
de Wit, 1991; Cheskin et al., 2005, also see D’Cunha et al.,
2013).
In laboratory animals, the effects of restricting food availability
on drug-associated behaviors have been demonstrated unequivo-
cally. The initiation and maintenance of drug intake are reliably
enhanced following periods of caloric restriction (Piazza and Le
Moal, 1998; Lu et al., 2003). Acute food deprivation (FD: 24–
48 h), can induce reinstatement to drug seeking in rats with a
history of heroin or cocaine self-administration (Shalev et al.,
2000, 2003). This effect is attenuated by antagonism of the stress
neuropeptide corticotropin-releasing factor (CRF) receptor, but
not the removal of corticosterone (Shalev et al., 2003, 2006), a pat-
tern of results similar to those obtained by Shaham et al. (1997)
in a study utilizing footshock as a stressor.
Interestingly, although both acute FD and chronic food restric-
tion (days to weeks) decrease BW and augment drug seeking
in rodents, they can have quite different metabolic and behav-
ioral effects on the organism. For example, Fulton et al. (2000)
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demonstrated a decreased threshold for electrical brain stim-
ulation reward in chronically food restricted but not acutely
food deprived rats. Similarly, increased cigarette smoking fol-
lowing prolonged food restriction, but not acute food depri-
vation, has been reported in human subjects (Zacny and de
Wit, 1992; Cheskin et al., 2005). In response to these find-
ings, we have recently developed a clinically relevant model, in
which drug seeking in drug-free rats with a history of heroin
self-administration is tested following prolonged food restric-
tion. Using this model, our laboratory has reported a dramatic
enhancement of heroin seeking in food restricted rats under going
withdrawal (>250%) compared to sated controls (D’Cunha et al.,
2013).
Although the extrahypothalamic CRF system is critically
involved in acute FD-induced reinstatement of heroin seeking
(Shalev et al., 2006), its role in chronic food restriction-induced
augmentation of drug seeking is not known. In addition, while
a key role for a stress-induced increase in corticosterone in
acute FD-induced reinstatement was ruled out (Shalev et al.,
2003, 2006), previous studies demonstrated that pharmacological
blockade of corticosterone synthesis or complete removal of cor-
ticosterone attenuates chronic food restriction-induced augmen-
tation of drug-related behaviors (Deroche et al., 1995; Marinelli
et al., 1996). Thus, the aim of this study was to investigate the
involvement of CRF and corticosterone, in the augmentation of




One hundred and thirty-three male, Long-Evans rats (Charles
River, St. Constant, Quebec, Canada; 300–350 g) were used.
Before surgery, animals were pair-housed for 1 week in the
animal care facility (ACF) under reverse light/dark conditions
(lights OFF at 0930). Following intravenous (IV) catheteri-
zation, and 2 days of recovery, rats were single-housed in
plastic shoebox cages before being transferred to operant
conditioning chambers for drug self-administration. Following
self-administration training, rats were returned to the ACF and
single-housed in shoebox cages for the drug withdrawal phase.
Except for the withdrawal phase, all rats were given unrestricted
access to food and water. Rats were treated according to the
Canadian Council on Animal Care guidelines, and approval was
granted by the Concordia University Animal Research Ethics
Committee.
SURGICAL PROCEDURES
Intravenous catheterization and intracerebroventricular (I.C.V.)
cannulation
Rats were implanted with IV silastic catheters (Dow Corning,
Midland,MI, USA) under xylazine/ketamine (13.0 + 90.0mg/kg;
i.p.). Three centimeters of silastic catheter was inserted through
a small incision on the right jugular vein, and secured using
silk sutures. The remainder of the catheter was passed subcuta-
neously to the skull, attached to a modified 22-gauge cannula
(Plastics One, Roanoke, VA) and anchored to the skull using den-
tal cement and 5 jeweler’s screws. Some rats (Experiment 1A)
were also implanted with a 22-gauge guide cannula (Plastics One)
aimed 2mm above the right or left lateral ventricle (AP, ±0.5;
ML, +1.4; DV, −3.0; relative to bregma) to allow for i.c.v.
injections.
Following surgery, rats were administered buprenorphine
(600.0μg/rat; s.c.; Schering-Plough Ltd., Welwyn Garden City
Hertfordshire, UK) and penicillin (450,000 IU/rat; s.c.) to reduce
pain and prevent infection. Catheters were flushed daily with hep-
arin/gentamicin (7.5 IU +12.0mg/rat) to prevent blockage and
infection.
Adrenalectomy
Bilateral adrenalectomy (ADX) surgeries were performed on
withdrawal day 10 on rats in Experiment 2B, under isoflurane
USP anesthetic. The adrenal glands were rapidly removed via the
dorsal approach, and the rats were given ketoprofen injections
(5.0mg/kg; s.c.) following surgery to reduce pain. Sham-operated
rats were exposed to the same procedure as the ADX rats, with
the exception that the adrenal glands were not removed. After
surgery, the ADX rats were given physiological saline (0.9%NaCl)
in their drinking bottles.
APPARATUS
Rats were housed individually in operant conditioning chambers
(Coulbourn Instruments, Allentown, PA, USA; 29.0 × 29.0 ×
25.5 cm) enclosed in sound attenuating wooden compartments
equipped with a fan. Each chamber was fitted with two retractable
levers (Coulbourn Instruments) mounted 9 cm above the floor
of the right sidewall. Responses on the “active” lever activated
the infusion pump and a cue-light/tone (Coulbourn Instruments,
Sonalert, 2.9 KHz) located above the lever. Responses on the
“inactive” lever had no programmable consequences. Rats were
attached to the infusion pump via a liquid swivel (Instec
Laboratories Inc., Boulder, CO, USA) and Tygon tubing shielded
with a metal spring.
DRUGS
Heroin HCl (a contribution from the National Institute for Drug
Abuse, Research Triangle Park, NC, USA) was dissolved in sterile
saline (5.0mg/ml) and then further diluted with saline, for each
rat according to BW to yield 0.1mg/kg/infusion.
R121919, the selective CRF1 receptor antagonist, was kindly
supplied by Dr. Kenner Rice (National Institute on Drug Abuse,
NIH, Baltimore, MD, USA). R121919 was dissolved in a 20%
β-Cyclodextrin (Sigma-Aldrich) sterile saline solution to a con-
centration of 10.0mg/ml and adjusted to a pH of 4.5. The
antagonist was injected (s.c.) at a final dose of 20.0mg/kg. A
solution of 20% β-Cyclodextrin mixed in sterile saline solution
was used as a vehicle injected at a volume of 2.0ml/kg. A simi-
lar dose of R121919 reduced both drug self-administration and
anxiety-like behaviors (Greenwell et al., 2009; Gutman et al.,
2010).
The non-selective CRF antagonist, α-helical CRF (Sigma-
Aldrich), was dissolved in sterile water to a concentration of
5.0μg/μl or 12.5μg/μl. α-helical CRF was injected i.c.v. over
2min at a rate of 1.0μl/min for a final dose of 10.0 or 25.0μg/rat.
Sterile water was used as a vehicle. Injections were made using
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a syringe pump (Harvard Apparatus, Holliston, MA, USA)
connected to a 10μl Hamilton syringe. This syringe was attached
via polyethylene-20 tubing to a 28-gauge injector (Plastics One)
that extended 2mm below the guide cannulae. The injector was
kept in place for 1min after the injections to allow for proper dif-
fusion of the drug. The doses for α-helical CRF were based on
previous reports (Baldwin et al., 1991; Krahn et al., 1986; Shalev
et al., 2006).
RU486, a glucocorticoid receptor antagonist, was dissolved
using a 25% β-Cyclodextrin (Sigma-Aldrich), 1% Tween-80
(Sigma-Aldrich), 2–3 drops of 1N HCl, and sterile water mix-
ture which also served as the vehicle. RU486 and vehicle solutions
were adjusted to a pH of ∼5.6 and injected (i.p.) at a dose of
30mg/kg (RU486), or a volume of 1ml/kg (vehicle). A simi-
lar dose was shown to attenuate stress-induced reinstatement of
alcohol seeking (Simms et al., 2012).
PROCEDURE
Self-administration
Following a 24-h habituation period in the chamber, rats were
trained to self-administer heroin in daily three 3-h sessions sep-
arated by 3-h intervals for 10 days. The first daily session began
shortly after the onset of the dark phase with the extension of
the active and inactive levers into the conditioning chamber, illu-
mination of a house-light and activation of the cue-light/tone
complex for 30 s. Responses on the active lever, which was
armed with a fixed ratio-1 schedule (FR-1), resulted in activa-
tion of the drug pump (5 s, 0.13ml/infusion) and the initiation
of a 20 s timeout during which the house-light was turned off
and the cue light/tone complex above the active lever was acti-
vated. During the timeout period, active lever responses were
recorded but not reinforced. Following each 3-h session, the
active lever was retracted whereas the inactive lever was not
retracted until 1 h before the first session of the following day.
Inactive lever responses were recorded but had no programmable
consequences.
DRUG WITHDRAWAL PHASE
Experiments 1A, 1B, and 2A
Following self-administration training, rats were individually
housed in the ACF, and given unrestricted access to food and
water for one drug-washout day. Rats were then divided into two
groups: food restricted (FDR) or Sated that were matched accord-
ing to BW, number of infusions, and active lever responses across
the last 5 days of training. Following the washout day, FDR rats
had their food removed and were fed ∼15 g of rat chow at 1330.
The amount of food was adjusted through 14 days of food restric-
tion to maintain the food restricted rats’ BW at ∼75–80% of the
Sated rats and 90% of their baseline BW.
Experiment 2B
Rats were treated as in Experiment 2A, except for the ADX surgery
that was performed on day 10 of withdrawal. Following surgery,
rats were given 25 g of food and allowed 1 day of recovery, after
which they were re-restricted to the previously described regi-
men and allowed 2 extra days of withdrawal to ensure their BWs
reached criteria.
DRUG-SEEKING TEST
Experiment 1A: the effect of treatment with the selective CRF1
receptor antagonist, R121919
On withdrawal day 14, rats were returned to the operant condi-
tioning chambers and attached to the metal spring. The drug-
seeking test consisted of a 1-h session during which active lever
responses had the same consequences as in training excluding the
availability of the drug. A subcutaneous injection of R121919 (0.0,
20.0mg/kg, s.c.) was administered 30min before the test session.
Experiment 1B: the effects of treatment with the non-selective CRF
receptor antagonist, α-helical CRF, on chronic food
restriction-induced augmentation of heroin seeking in the rat
The testing procedure was similar to the one described for
Experiment 1A, except that the rats were given an ICV injection
of α-helical CRF (0.0, 10.0 or 25.0μg/rat, i.c.v.) 10min before the
test session.
Experiment 1C: the effects of treatment with the non-selective CRF
receptor antagonist, α-helical CRF, on open-field behavior
This experiment was designed to verify the efficiency of the
α-helical CRF treatment used in Experiment 1B. Previously, α-
helical CRF has been shown to have anxiolytic properties (Koob
and Heinrichs, 1999). To ensure that the antagonist had similar
effects in our hands, eight rats that participated in Experiment 1B
were given a test for anxiety. These rats were food restricted for
an additional 8 days following the drug-seeking test and on day
8 at 1330, were brought into a novel, brightly lit, environment
and placed in a white circular arena (diameter 137 cm; height
46 cm) with one food pellet in the center. Rats were placed at
either the north, south, west, or east positions of the arena and
allowed to explore the environment for 10min. The rats’ behavior
was recorded by a video camera. Two variables were then scored
from the video recordings. The first, latency to consumption, was
defined as the time for the rat to first consume a portion of the
food pellet. The second, number of approaches, was defined as
the number of times a rat approached the food pellet until first
consumption.
Experiment 2A: the effect of treatment with the glucocorticoid
receptor antagonist, RU486
Testing procedure was similar to the one described for
Experiment 1A, except that the rats were given an injection of
RU486 (30.0mg/kg, i.p.) or vehicle in the ACF 45min before the
test session.
Experiment 2B: the effect of ADX
Testing procedure was similar to the one described for
Experiment 1A, except that, other then the ADX surgery, no
further treatment was given before the test.
Plasma corticosterone determination
Immediately following the drug-seeking test (1030), tail blood
was collected, and plasma was separated by centrifugation at
10,000 rpm for 10min. Samples were stored at −80◦C. Plasma
samples were analyzed for corticosterone levels using a corticos-
terone specific enzyme-linked immunosorbent assay (ELISA) kit
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(Enzo Life Sciences: Cedarlane, Burlington, ON, Canada). The
reported detection sensitivity for the kit is 27.0 pg/ml.
STATISTICAL ANALYSIS
All analyses were conducted using SPSS software (IBM, SPSS
Statistics, version 20). Training data for all rats were analyzed
using a repeated measures ANOVA, with training day (1–10) as
a within-subjects factor and the number of active lever responses,
inactive lever responses or number of infusions as the dependent
variables.
Experiment 1
Number of responses on the active and inactive levers during the
drug-seeking test sessions were analyzed separately using Two-
Way ANOVAs. Antagonist dose (Experiment 1A: 0.0, 20.0mg/kg;
Experiment 1B: 0.0, 10.0, 25.0μg/rat) and feeding condition
(FDR, Sated) served as between subject factors.
The effect of treatment with α-helical CRF (0.0, 25.0μg/rat)
on the open field behavior was analyzed using two indepen-
dent samples t-tests. Latency to consumption and number of
approaches were the dependent variables.
Experiment 2
Number of responses on the active and inactive levers during the
test session were analyzed separately using Two-Way ANOVAs.
Antagonist dose (Experiment 2A: 0.0, 30.0mg/kg) or surgery con-
dition (Experiment 2B: ADX, Sham) and feeding condition (FDR,
Sated) served as the between subject factors.
Plasma corticosterone levels (ng/ml), sampled following the
test sessions in Experiment 2, were analyzed using a Two-
Way ANOVA. Antagonist dose (Experiment 2A: 0.0, 30.0mg/kg)
or surgery condition (Experiment 2B: ADX, Sham) and feed-
ing condition (FDR, Sated) served as the between subject
factors.
In all analyses, statistically significant interactions were investi-
gated with the appropriate post-hoc tests and the critical threshold
for statistically significant results was set at p ≤ 0.05.
RESULTS
All rats acquired reliable heroin self-administration behavior.
Mean ± SEM number of infusions and number of active and
inactive lever responses made on the last day of heroin self-
administration training, for each experiment, are shown in
Table 1. There were no statistically significant differences in any of
the above parameters between the different experimental groups
within each experiment.
Table 1 | Mean ± SEM number of heroin infusions and active and
inactive lever responses made on the last day of training (9h) in each
experiment.
Infusions Active lever Inactive lever
Experiment 1A 42.08 ± 4.25 155.72 ± 18.97 13.28 ± 3.36
Experiment 1B 35.06 ± 1.91 99.62 ± 13.40 6.90 ± 0.84
Experiment 2A 40.23 ± 4.60 141.62 ± 23.45 18.00 ± 8.27
Experiment 2B 36.72 ± 2.84 116.66± 17.77 25.03 ± 6.01
EXPERIMENT 1A: THE EFFECTS OF TREATMENT WITH THE SELECTIVE
CRF1 RECEPTOR ANTAGONIST, R121919, ON CHRONIC FOOD
RESTRICTION-INDUCED AUGMENTATION OF HEROIN SEEKING IN
THE RAT
Five rats were removed due to catheter leakage, failure to train,
or detached head-cap. Thus, the final analysis included 25 rats
in 4 experimental groups: FDR-0.0 (n = 5), FDR-20.0 (n = 7),
Sated-0.0 (n = 6), Sated-20.0 (n = 7). On the test day, average
BW of the rats in the Sated group (n = 13; 452.92 ± 9.65 g) was
statistically significantly greater than that of the rats in the FDR
group (n = 12; 333.50 ± 6.47 g; t(23) = −10.12, p < 0.001).
The mean number of active lever responses performed by the
rats in the FDR group was almost three times higher than the
lever responses made by the Sated group during the drug-seeking
test. The robust effect was confirmed by a statistically significant
main effect of feeding condition [F(1, 21) = 6.91, p = 0.016, η2 =
0.24; Figure 1A]. No statistically significant effects were found for
FIGURE 1 | The effect of treatment with the selective CRF1 receptor
antagonist, R121919 (0.0, 20.0mg/kg, s.c.) on heroin seeking in
food-restricted (FDR) and sated rats under withdrawal; Experiment 1A.
Data shown are the mean (+SEM) numbers of active (A) and inactive (B)
lever responses made on test day by rats in the FDR (n’s: FDR-0.0 = 6,
FDR-20.0 = 7) and Sated (n’s: Sated-0.0 = 5, Sated-20.0 = 7) groups. Test
day consisted of one 1-h drug-seeking session under extinction conditions,
following heroin self-administration training and 14 days of withdrawal
under FDR or sated conditions. ∗Significantly different from the sated
condition, p = 0.016.
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antagonist dose or for the interaction feeding condition × antag-
onist dose. No statistically significant effects were observed for
inactive lever responding on the test day (Figure 1B).
EXPERIMENT 1B: THE EFFECTS OF TREATMENT WITH THE
NON-SELECTIVE CRF RECEPTOR ANTAGONIST, α-HELICAL CRF, ON
CHRONIC FOOD RESTRICTION-INDUCED AUGMENTATION OF HEROIN
SEEKING IN THE RAT
Eight rats were removed due to catheter leakage, failure to train
or detached head-caps. Therefore, the final analysis included 52
rats in 6 experimental groups: FDR-0.0 (n = 8), FDR-10.0 (n =
11), FDR-25.0 (n = 7), Sated-0.0 (n = 10), Sated-10.0 (n = 11),
Sated-25.0 (n = 5). On test day, the average BWs of rats in
the Sated group (n = 26; 439.62 ± 9.27 g) was statistically sig-
nificantly greater than that of rats in the FDR groups (n = 26;
333.08 ± 4.17 g; t(50) = −10.48, p < 0.001).
Rats in the FDR group made a higher number of responses
on the active lever during the drug-seeking test, compared to
the Sated group (see Figure 2A). This finding was supported
FIGURE 2 | The effect of treatment with the non-specific CRF receptor
antagonist, α-Helical CRF (0.0, 10.0, 25.0 μg/rat, i.c.v.) on heroin
seeking in food-restricted (FDR) and sated rats under withdrawal;
Experiment 1B. Data shown are the mean (+SEM) numbers of active (A)
and inactive (B) lever responses made on test day by rats in the FDR (n’s:
FDR-0.0 = 8, FDR-10.0 = 11, FDR-25.0 = 7) and Sated (n’s: Sated-0.0 = 10,
Sated-10.0 = 11, Sated-20.0 = 5) groups. Test day consisted of one 1-h
drug-seeking session under extinction conditions, following heroin
self-administration training and 14 days of withdrawal under FDR or sated
conditions. ∗Significantly different from the sated condition, p < 0.001.
by a statistically significant main effect of feeding condition,
[F(1, 46) = 17.68, p < 0.001, η2 = 0.27]. No statistically signifi-
cant effects were found for either the antagonist dose or for the
feeding condition × antagonist dose interaction. No significant
effects were observed for inactive lever responding on test day
(Figure 2B).
EXPERIMENT 1C: THE EFFECT OF TREATMENT WITH THE
NON-SELECTIVE CRF RECEPTOR ANTAGONIST, α-HELICAL CRF ON
OPEN-FIELD BEHAVIOR
Rats in the α-helical CRF-treated group demonstrated a statisti-
cally significant decrease in latency to first food consumption and
the number of approaches prior to first consumption, compared
to vehicle controls [t(5) = 2.80, p = 0.038; Figure 3A; t(5) = 3.13,
p = 0.021; Figure 3B, respectively].
EXPERIMENT 2A: THE EFFECT OF TREATMENT WITH THE
GLUCOCORTICOID RECEPTOR ANTAGONIST, RU486, ON CHRONIC
FOOD RESTRICTION-INDUCED AUGMENTATION OF HEROIN SEEKING
IN THE RAT
Three rats were removed due to catheter leakage, failure to train or
being an outlier. Therefore, the final analysis included 27 rats in 4
experimental groups: FDR-0.0 (n = 7), FDR-30.0 (n = 7), Sated-
0.0 (n = 8), Sated-30.0 (n = 5). On test day, average BW of the
rats in the Sated group (n = 13; 426.23 ± 8.02 g) was statistically
significantly greater than that of the rats in the FDR group (n =
14; 317.36 ± 5.21 g; t(25) = −11.54, p < 0.001).
As can be seen in Figure 4A, the FDR group showed more
active lever responding than the Sated group, [feeding con-
dition effect: F(1, 23) = 8.46, p = 0.008, η2 = 0.26] during the
drug-seeking test. No statistically significant effects for antago-
nist dose or feeding condition × antagonist dose interaction were
observed. The FDR group also responded more on the inactive
lever than the Sated group [feeding condition effect: F(1, 23) =
FIGURE 3 | The effect of treatment with the non-specific CRF receptor
antagonist α-Helical CRF (0.0, 25.0 μg/rat, i.c.v.) on behavior in an
open field, following an 8-day food restriction period; Experiment 1C.
Data shown are the mean (+SEM) latencies to first consumption of (A) and
number of approaches to (B) a food pellet placed at the center of an open
arena following injections of α-Helical CRF in food restricted rats (n’s: 0.0 =
4, 25.0 = 3). ∗p = 0.038; & p = 0.021.
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FIGURE 4 | The effect of treatment with the glucocorticoid receptor
antagonist, RU486 (0.0, 30.0mg/kg, i.p.) on heroin seeking in
food-restricted (FDR) and sated rats under withdrawal; Experiment 2A.
Data shown are the mean (+SEM) numbers of active (A) and inactive (B)
lever responses made on test day by rats in the FDR (n’s: FDR-0.0 = 7,
FDR-30.0 = 7) and Sated (n’s: Sated-0.0 = 8, Sated-30.0 = 5) groups. Test
day consisted of one 1-h drug-seeking session under extinction conditions,
following heroin self-administration training and 16 days of withdrawal
under FDR or sated conditions. ∗Significantly different from the sated
condition, p < 0.02.
6.42, p = 0.019, η2 = 0.19; Figure 4B]. However, the number of
inactive lever responses was very low (<25) and the rats clearly
preferred the active lever.
Some corticosterone samples that were collected immediately
following the test session were not included in the final anal-
ysis due to an unacceptable variability between the duplicates
in the ELISA kit (>30%). Administration of RU486 resulted in
increased levels of corticosterone in both the sated and FDR
rats. However, treatment with RU486 resulted in considerably
higher corticosterone levels in the FDR group (Figure 5). ANOVA
revealed statistically significant main effects of feeding condi-
tion [F(1, 15) = 12.80, p = 0.003, η2 = 0.30] and antagonist dose
[F(1, 15) = 14.13, p = 0.002, η2 = 0.34], and a significant feeding
condition × antagonist dose interaction effect [F(1, 15) = 7.15,
p = 0.017, η2 = 0.17]. Although this significant interaction effect
was clearly driven by the dramatic increase in corticosterone
FIGURE 5 | The effect of treatment with the glucocorticoid receptor
antagonist, RU486 (0.0, 30.0mg/kg, i.p.) on corticosterone levels;
Experiment 2A. Data shown are the mean (+SEM) corticosterone levels
(ng/ml) immediately following a drug-seeking test session under extinction
conditions, in food restricted rats (n’s: 0.0 = 6, 30.0 = 3) and Sated rats (n’s:
0.0 = 6, 30.0 = 4). ∗Significantly different from the 0.0mg/kg group,
p < 0.020; #Significantly different from the Sated-0.0 group, p = 0.03; &
p = 0.07 compared to the Sated-30.0 group.
levels induced by the RU486 treatment in the FDR rats, corti-
costerone levels in this group were not statistically significantly
different from the sated, RU486-treated rats [t(5) = 2.33, p =
0.07, Cohen’s d = 2.08], probably due to the sample size in the
FDR, RU486-treated group (n = 3). Further post-hoc tests are
described in Figure 5.
EXPERIMENT 2B: THE EFFECT OF ADRENALECTOMY ON CHRONIC
FOOD RESTRICTION-INDUCED AUGMENTATION OF HEROIN SEEKING
IN THE RAT
Three rats were removed due to catheter leakage, failure to train
or detached head-caps. Thus, the final analysis included 29 rats
in 4 experimental groups: FDR-Sham= 6, FDR-ADX = 7, Sated-
Sham = 7, Sated-ADX = 9.
On test day, the average BW of the Sated group (Sham:
391.57 ± 10.41 g; ADX: 396.89 ± 4.37 g) was statistically sig-
nificantly greater [feeding condition: F(1, 25) = 108.85, p <
0.0001] than the FDR group’s BW (Sham: 310.17 ± 8.63 g; ADX:
312.00 ± 9.19 g). No statistically significant effects on BW for
surgery group or the feeding condition × surgery group inter-
action were observed.
As can be seen in Figure 6A, the FDR group pressed the
active lever more than the Sated group [feeding condition effect:
F(1, 25) = 19.19, p < 0.001, η2 = 0.40] during the drug-seeking
test. No statistically significant effects for surgery group or the
feeding condition× surgery group interaction were observed. No
significant effects were observed for inactive lever responding on
test day (Figure 6B).
As expected, corticosterone levels in adrenalectomized rats
were very low (<5 ng/ml), and were not affected by food restric-
tion (data not shown).
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FIGURE 6 | The effect of adrenalectomy on heroin seeking in
food-restricted (FDR) and sated rats under withdrawal; Experiment 2B.
Data shown are the mean (+SEM) numbers of active (A) and inactive (B)
lever responses made on test day by rats in the FDR (n’s: FDR-SHAM = 6,
FDR-ADX = 7) and Sated (n’s: Sated-SHAM = 7, Sated-ADX = 9). Test day
consisted of 1-h drug-seeking session under extinction conditions, following
heroin self-administration training and 16 days of withdrawal under FDR or
sated conditions. *Significantly different from the sated condition, p < 0.001.
DISCUSSION
Recent work in our laboratory has demonstrated an augmenta-
tion of heroin seeking in chronically food restricted rats, under
withdrawal (D’Cunha et al., 2013). Thus, as expected, a pro-
longed period of food restriction resulted in a robust increase in
heroin seeking, compared to sated rats, across all experimental
groups in the current study. In contrast to the robust attenu-
ation of acute food deprivation-induced reinstatement of drug
seeking following treatment with CRF-receptor antagonists, treat-
ment with R121919, a selective CRF1-R antagonist, or α-helical
CRF, a non-specific CRF-R antagonist, did not result in a statis-
tically significant reduction in heroin seeking in food restricted
rats under withdrawal. Similarly, neither treatment with RU486,
a glucocorticoid receptor antagonist, nor adrenalectomy affected
heroin seeking in this model.
Our findings are consistent with considerable evidence sup-
porting a modulatory role for food restriction on drug-related
behaviors in humans (Hall et al., 1992; Krahn et al., 1992; Cheskin
et al., 2005) and in laboratory animals, where food deficiency
drastically influences drug taking and the reinforcing properties
of abused drugs (Carroll and Meisch, 1984; Stuber et al., 2002;
Carr, 2007).
Despite previous evidence demonstrating that CRF1-R antag-
onists attenuate acute food deprivation-induced reinstatement
of extinguished cocaine and heroin seeking (Shalev et al., 2003,
2006), the experiments described here suggest that these findings
do not extend to chronic food restriction-induced augmenta-
tion of heroin seeking in rats under withdrawal. The observed
lack of effect for CRF-R antagonists in chronically food-restricted
rats may be due to the differential effects of food restriction and
deprivation on metabolism and behavior (Fulton et al., 2000)
or differences between the reinstatement model and the with-
drawal procedure used here. First, rats in the present study did
not undergo a period of extinction. Extinction training and with-
drawal (without extinction) result in activation of distinct neural
circuits during drug-seeking tests (Fuchs et al., 2008), which
might be differentially modulated by the CRF system. Second,
our current study employed a prolonged period of mild stress
induced by food restriction (Deroche et al., 1995) compared
to the acute 24–48 h food deprivation we have used previously.
Alterations in gene expression suggest that different neural adap-
tations occur following exposure to acute and chronic stress. For
example, increased CRF1-R and c-fos mRNA in the paraventric-
ular nucleus of the hypothalamus (PVN) are observed following
acute, but not chronic stress. In contrast, chronic stress results in
lowered levels of CRF1-R and c-fos mRNA in the PVN (Bonaz
and Rivest, 1998). However, other reports have demonstrated the
opposite result, where increased levels of CRF1-R mRNA in the
PVN were reported following chronic but not acute stress (Imaki
et al., 1991). Notwithstanding these inconsistencies, there appear
to be distinct adaptations in the CRF system following exposure
to acute or chronic stress.
In the present study, rats were exposed to a 14-day food
restriction stress, which may have resulted in progressive CRF-
induced adaptations in critical neuronal circuits over the with-
drawal period. For example, greater dopamine (DA) tissue levels
in the nucleus accumbens (NAc), and reduced levels in the
prefrontal cortex (PFC), were found 1 week following the com-
pletion of a chronic treatment (13 days) with CRF (Izzo et al.,
2005). Moreover, differential effects for acute vs. chronic treat-
ment with CRF antagonists are suggested by findings of Mällo
et al. (2004) who reported a reduction in anxiety (as defined
by increased exploration) in an elevated-zero-plus-maze test fol-
lowing chronic, but not acute treatment with a selective CRF1-R
antagonist. Consequently, acute CRF-R activation during the test
may no longer be necessary to demonstrate the augmentation of
heroin seeking in food restricted rats. Future studies should inves-
tigate the effects of chronic CRF-R antagonist treatment, over
the withdrawal period, on the augmentation of heroin seeking
induced by chronic food restriction.
An interesting, albeit not statistically significant, trend for a
dose dependent reduction in responding on the previously heroin
paired (active) lever on the test day was observed in the α-helical
CRF-treated sated group. Recently, CRF-R antagonismwas shown
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to reduce cue-induced reinstatement of drug seeking (Moffett
and Goeders, 2006), which could provide a possible explanation
for the reduction of active lever responding observed in sated
rats in the current experiments, following exposure to the drug-
associated environment and cues. However, a similar pattern was
found for inactive lever responding in the food restricted and
sated groups, suggesting that the reduced lever seeking in the α-
helical CRF-treated rats was not due exclusively to changes in the
motivational value of the drug-associated stimuli. Furthermore,
administration of R121919 did not reduce active or inactive lever
responding in the drug treated groups, further supporting a
lack of motivational effects for CRF-R antagonists in the cur-
rent procedure. It is possible that treatment with α-helical CRF
resulted in an overall reduction of locomotor responding, which
was obscured by the increased drug-seeking behavior in the food
restricted rats; yet, we found no indication for such an effect in
the previous studies conducted in our laboratory (Shalev et al.,
2006).
To ensure the efficiency of the treatment with α-helical CRF,
its effect on anxiety-related behaviors was investigated. In this
test a reduction in anxiety was assessed by the latency to con-
sume a food pellet placed in the center of an open field, and
the number of approaches made prior to finally consuming
the food. We found shorter latencies and reduced number of
approaches made before food consumption in food restricted rats
that received α-helical CRF treatment. Rats that did not receive
the drug treatment approached the food multiple times with no
attempt at consumption and would instead continue to explore
the environment.
To gain a better understanding of the involvement of the
physiological stress response in food restriction-induced augmen-
tation of heroin seeking, we investigated the role of corticos-
terone, the major stress-associated hormone. Chronically food
restricted rats exhibit greater levels of corticosterone compared
to controls (Carr, 1996). Furthermore, the elevated concentra-
tions observed following food restriction are positively associated
with the proclivity to self-administer cocaine. Additionally, the
removal of corticosterone via adrenalectomy can also decrease the
psychostimulant challenge-induced heightened locomotor activ-
ity observed in food restricted rats (Deroche et al., 1995; Piazza
and Le Moal, 1996). It can be argued that the lack of effect follow-
ing treatment with CRF-R antagonists indicates that the complete
HPA-axis is not involved in food restriction-induced augmen-
tation of heroin seeking. However, plasma levels of adrenocor-
ticotropic hormone (ACTH) and the subsequent production of
corticosterone can be affected by mechanisms independent of
CRF’s actions in the HPA axis (Tsigos and Chrousos, 2002).
In the current study, neither acute treatment with a glu-
cocorticoid antagonist, RU486, nor adrenalectomy reduced the
increased heroin seeking observed in chronically food-restricted
rats under withdrawal. These results are consistent with past
studies in the literature on stress- and reward-related behaviors.
In CRF deficient mice, activity in an anxiety provoking situa-
tion (e.g., elevated plus maze) remains unaffected, in spite of a
blunted HPA axis response and lowered concentrations of corti-
costerone (Dunn and Swiergiel, 1999). Therefore, a heightened
physiological stress response may not always be necessary for
the expression of stress-related behaviors. Abrahamsen and
Carr (1996) demonstrated that in a lateral hypothalamus self-
stimulation procedure, the sensitization of the rewarding effects
of the stimulation by food restriction is unaltered following a
treatment with a corticosterone synthesis inhibitor or an acute
feeding-induced decrease in plasma corticosterone (Abrahamsen
et al., 1995). The aforementioned studies argue against a modula-
tory role for corticosterone in rewarding-seeking. As Carr (2002)
suggests, however, themost comprehensive test of corticosterone’s
involvement in food restriction would be to maintain corticos-
terone concentrations in the food restricted group at similar
concentrations as those reported in the sated controls over the
full period of restriction. A recent study from DiLeone’s group
(Guarnieri et al., 2012) offers further support for a mediating role
for corticosterone in the effects of food restriction on motivation.
Guarnieri et al. (2012) report that 5 days of mild food restriction
in mice resulted in an upregulation of genes in the mesocor-
ticolimbic system that are associated with the stress response.
These changes in gene expression were critically dependent on
food restriction-induced increases in corticosterone levels, and
the hormone was also shown to be important for the poten-
tiation of food seeking in food restricted mice. The authors
suggest that the identified genes are the molecular signals that
drive food restriction-induced behavioral plasticity (Guarnieri
et al., 2012). It is important to note, however, that some of these
corticosterone-dependent changes in gene expression were trig-
gered following only 1 day of food restriction. In contrast, we
have reported that a short-term food restriction period (3–5
days) is not sufficient to induced augmentation of heroin seek-
ing (D’Cunha et al., 2013), suggesting that different, slower to
develop, adaptations underlie this phenomenon.
Concentrations of corticosterone were statistically significantly
greater in food restricted and sated rats after treatment with
RU486 compared to the vehicle pretreatment. Interestingly, the
magnitude of increase in the food-restricted group (∼500%) was
greater than that in the sated group (∼74%) following RU486
treatment. We speculate that these differences in magnitude can
be explained by the lack of negative feedback from circulating
corticosterone, which resulted in amplification of the increased
corticosterone levels that are typically found in food restricted
rats.
There is evidence that the augmentation of drug seeking fol-
lowing food restriction can be modulated by homeostatic mech-
anisms that are triggered by the hunger state (Cabeza de Vaca
and Carr, 1998). For example, infusions of ghrelin, an orexigenic
gut hormone, can increase extracellular DA concentrations in the
NAc (Jerlhag et al., 2007), and cocaine-induced increases of extra-
cellular DA in the NAc are attenuated by ghrelin receptor antago-
nism (Jerlhag et al., 2010). Importantly, increased serum concen-
trations of ghrelin have been observed in response to cue-induced
reinstatement of cocaine seeking (Tessari et al., 2007), suggest-
ing an involvement of the peptide in the conditioned reinforcing
effects of cocaine. However, the involvement of ghrelin in cocaine
seeking and taking might not be easily generalized to other
drugs. Treatment with a ghrelin antagonist did not impair food
deprivation-induced reinstatement of heroin seeking, although
central infusions of ghrelin did increase the breakpoints on a
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progressive ratio schedule of heroin reinforcement (Maric et al.,
2011). It is critical to note that the aforementioned study used
acute food deprivation in a reinstatement of extinguished drug
seeking procedure, which as mentioned above, might involve dif-
ferent brain mechanisms than prolonged food restriction in rats
under withdrawal.
An additional peripheral signal that is involved in energy bal-
ance is leptin, an anorexigenic hormone that is secreted by periph-
eral adipocytes (Friedman and Halaas, 1998). Leptin can regulate
activity in the mesocorticolimbic circuitry through its actions on
ventral tegmental area (VTA) DA neurons, and has been impli-
cated in reward processes (Fulton et al., 2000). Interestingly,
leptin was shown to attenuate acute food deprivation-induced
reinstatement of heroin seeking (Shalev et al., 2001). However,
this effect was not observed with footshock stress- or heroin
priming-induced reinstatement (Shalev et al., 2001), suggesting
that leptin’s effect on acute food deprivation-induced reinstate-
ment was not mediated by DA or stress-related pathways. In
contrast, it is possible that in chronically food-restricted rats, as
in the current study, the decrease in leptin signal contributed
to the sensitized response to the drug-associated cues through
disinhibition of the mesocorticolimbic DA system (Hommel
et al., 2006).
In conclusion, we suggest that pathways involved in the acute
stress response are not critical for the expression of augmented
drug seeking in food-restricted rats under withdrawal. Our find-
ings, however, do not exclude a role for food restriction-induced
prolonged increases in CRF and corticosterone in the induction
of downstream brain adaptations, which in turn may drive the
augmented drug seeking observed in rats under withdrawal from
heroin.
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